Back to the main directory
Press Release
- Rapid7 to Participate in Upcoming Investor Conferences by GlobeNewsWire
- Zumiez Inc. to Report Fiscal 2025 First Quarter Results by GlobeNewsWire
- Inotiv, Inc. to Present at Jefferies Global Healthcare Conference 2025 by GlobeNewsWire
- PennantPark Floating Rate Capital Ltd.’s Unconsolidated Joint Venture, PennantPark Senior Secured Loan Fund I LLC Completes the Reset of its $315.8 Million Securitization, Lowering the Cost of Financing by GlobeNewsWire
- TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference by GlobeNewsWire
- Epsilon Announces 2025 AGM Results by GlobeNewsWire
- GENFIT Reports First Quarter 2025 Financial Information by GlobeNewsWire
- Dianthus Therapeutics Appoints Simon Read, Ph.D., to Board of Directors by GlobeNewsWire
- Chemung Financial Corporation Announces Quarterly Dividend by GlobeNewsWire
- Quanex Building Products Announces Second Quarter 2025 Earnings Release and Conference Call Schedule by GlobeNewsWire
- Uniti Group Inc. to Participate at the Goldman Sachs 10th Annual Leveraged Finance and Credit Conference by GlobeNewsWire
- Stifel Reports April 2025 Operating Data by GlobeNewsWire
- Inventus Mining Closes $1M Flow-Through Private Placement With Eric Sprott by GlobeNewsWire
- Red River Bancshares, Inc. Announces Quarterly Cash Dividend by GlobeNewsWire
- Crown LNG Holdings Limited Discloses Receipt of NASDAQ Notice by GlobeNewsWire
- Medallion Bank Announces Closing of Series G Preferred Stock Offering by GlobeNewsWire
- First Capital, Inc. Announces Quarterly Dividend by GlobeNewsWire
- Serina Therapeutics Appoints Stephen Brannan, M.D. to Board of Directors by GlobeNewsWire
- Zymeworks Announces Presentations Highlighting Breadth of Oncology Portfolio at Upcoming Medical Conferences by GlobeNewsWire
- Bicara Therapeutics Announces Publication of an Abstract with Updated Interim Data from Phase 1/1b Trial of Ficerafusp alfa in 1L R/M HNSCC at the 2025 ASCO Annual Meeting by GlobeNewsWire
- Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting by GlobeNewsWire
- Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting by GlobeNewsWire
- Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting by GlobeNewsWire
- IMUNON Announces Withdrawal of Form S-1 Registration Statement by GlobeNewsWire
- Cullinan Therapeutics, Taiho Pharmaceutical, and Taiho Oncology to Present Positive Results from Pivotal Phase 2b REZILIENT1 Trial of Zipalertinib at ASCO 2025 by GlobeNewsWire